- Home
- REXR vs MEDP Comparison
REXR vs MEDP Comparison
Compare REXR & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- MEDP
- Stock Information
- Founded
- REXR 2013
- MEDP 1992
- Country
- REXR United States
- MEDP United States
- Employees
- REXR N/A
- MEDP N/A
- Industry
- REXR Real Estate Investment Trusts
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- REXR Real Estate
- MEDP Health Care
- Exchange
- REXR Nasdaq
- MEDP Nasdaq
- Market Cap
- REXR 8.6B
- MEDP 8.5B
- IPO Year
- REXR 2013
- MEDP 2016
- Fundamental
- Price
- REXR $40.43
- MEDP $463.64
- Analyst Decision
- REXR Hold
- MEDP Hold
- Analyst Count
- REXR 9
- MEDP 10
- Target Price
- REXR $40.00
- MEDP $406.89
- AVG Volume (30 Days)
- REXR 2.0M
- MEDP 403.1K
- Earning Date
- REXR 10-15-2025
- MEDP 07-21-2025
- Dividend Yield
- REXR 4.26%
- MEDP N/A
- EPS Growth
- REXR 11.21
- MEDP 26.42
- EPS
- REXR 1.35
- MEDP 13.46
- Revenue
- REXR $986,532,000.00
- MEDP $2,231,787,000.00
- Revenue This Year
- REXR $9.25
- MEDP $19.15
- Revenue Next Year
- REXR $6.55
- MEDP $9.35
- P/E Ratio
- REXR $30.00
- MEDP $34.45
- Revenue Growth
- REXR 13.72
- MEDP 9.94
- 52 Week Low
- REXR $29.68
- MEDP $250.05
- 52 Week High
- REXR $52.61
- MEDP $501.30
- Technical
- Relative Strength Index (RSI)
- REXR 68.99
- MEDP 64.46
- Support Level
- REXR $38.81
- MEDP $452.77
- Resistance Level
- REXR $39.86
- MEDP $469.41
- Average True Range (ATR)
- REXR 0.78
- MEDP 10.32
- MACD
- REXR 0.31
- MEDP -3.01
- Stochastic Oscillator
- REXR 94.59
- MEDP 84.53
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.